Objective: To evaluate the incidence of ileus and gastrointestinal morbidity in patients who received immediate postoperative feeding and bowel stimulation after undergoing major gynecologic surgical procedures.
A major complication of abdominal surgical procedures is postoperative ileus (colonic stasis), which results in patient discomfort, prolonged length of hospital stay, and increased cost of treatment. 1 Each occurrence of postoperative ileus is estimated to cost $5000 to $10,000, or a total of $1 billion per year in the United States. 2 The exact mechanism that produces postoperative ileus is unknown, but possible origins include gastrointestinal inflammatory response, stimulation of the mesenteric plexus, anesthesia, and use of opioid analgesics. The final pathway to postoperative ileus is believed to be associated with activation of the gastrointestinal μ-opioid receptors, which disrupts peristalsis in the rectosigmoid and leads to uncoordinated nonpropulsive contractions. Peristalsis typically returns to normal approximately 3 days after a surgical procedure. 3 The incidence of postoperative ileus after gynecologic surgery ranges from 5% to 25%, with the mean incidence being 10% to 15%. [4] [5] [6] [7] [8] [9] Immediate postoperative feeding and bowel stimulation has been shown to be effective in preventing postoperative ileus. 3 The exact mechanism of early postoperative feeding's effect on ileus is unknown, but possible origins include stimulation of the cephalic-vagal response, stimulation of gastrointestinal hormones (eg, nitric oxide, vasoactive intestinal peptide, substance P), and direct tropic effect. The purpose of bowel stimulation is to directly override rectosigmoid paralysis.
We have previously reported findings from 2 trials 10,11 of early postoperative feeding and bowel stimulation after radical hysterectomy that showed decreased length of stay and no reports of ileus. For the present prospective study, we evaluated the incidence of ileus and gastrointestinal morbidity in all patients who underwent a major gynecologic surgical procedure performed by the senior author (J.F.) during a 5-year study period. All patients received the same postoperative orders, which included immediate feeding and bowel stimulation. To our knowledge, this is the largest trial to evaluate the efficacy of immediate postoperative feeding and bowel stimulation in preventing ileus after major gynecologic surgical procedures.
Methods
The present prospective study took place during a 5-year period (2004) (2005) (2006) (2007) (2008) (2009) ) at 2 hospitals in a major city. During the study period, the senior author (J.F.) entered information for all patients on whom he performed a major gynecologic surgical
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procedure into a prospective surgical database (Microsoft Excel 2007; Microsoft Corporation, Redmond, Washington). Demographics were obtained and entered preoperatively, surgical outcomes were entered immediately postoperatively, and findings of follow-up examinations were entered for the first 30 days. All patients were examined at 1 and 4 weeks postoperatively. Patients with cancer were also examined every 3 to 6 months for 5 years, but findings of long-term follow-up examinations were not included in the present study.
Patient inclusion criteria consisted of major gynecologic procedures and included the following: laparoscopic-assisted salpingo-oophorectomy for ovarian masses longer than 15 cm, laparoscopic hysterectomy and lymphadenectomy, laparoscopic hysterectomy for fibroids weighing more than 500 g, 15 laparoscopic radical hysterectomy, 12 laparoscopicassisted ovarian debulking, 13 laparoscopic ovarian cancer staging, 14 modified radical vulvectomy, debulking and bowel resection with laparotomy, ovarian debulking with laparotomy, and vaginal hysterectomy for endometrial cancer in patients weighing more than 350 lb. 16 Postoperative instructions were the same for all patients and were entered into a computerized physician order entry system. These instructions included immediate postoperative feeding of a diet of choice and bowel stimulation with 30 mL of magnesium hydroxide (milk of magnesia) twice daily until bowel movements occurred. No patient had elective postoperative nasogastric tube decompression. All patients received extensive pre-and postoperative education concerning ileus and bowel stimulation, including instructions to eat a diet of choice when hungry and to continue milk of magnesia twice daily until bowel movement. The senior author personally ensured compliance of diet and bowel stimulation on postoperative day 1 rounds.
All patients underwent a preoperative bowel preparation with 10 oz of magnesium citrate, received a single 500 mg dose of cefazolin sodium if indicated, used pneumatic compression stockings, and performed early ambulation. Unless contraindicated, all patients received ketorolac tromethamine (30 mg intravenously), morphine (2-5 mg intravenously every 2 hours as needed), and acetaminophen and oxycodone hydrochloride (325 mg-5 mg, 1-2 tablets orally every 6 hours as needed) for analgesia after the operation.
Ileus is defined as the inhibition of bowel motility. The definition of postoperative ileus, however, varies from prolonged absences of flatus to insertion of nasogastric tube decompression to readmission for vomiting. [1] [2] [3] [4] [5] [6] [7] [8] [9] For the present study, we liberally defined postoperative ileus as either any instance in which a patient's hospital discharge was delayed 1 day or longer because of inadequate oral intake or any instance when a patient was readmitted because of nausea. Because patients were routinely discharged by 9 AM the morning after the operation, the time to flatus and bowel movement was not documented.
Institutional review board approval was obtained for the present study.
Results
During the 5-year study period, 707 patients met the study criteria. Information for all patients was entered into the database, and no patients were excluded or lost to follow-up. Median age of the 707 patients was 61 years (range, 19-94 years) and median body mass index was 32 kg/m 2 (range, 18-76 kg/m 2 ). Six hundred sixty-five patients (94%) were white. Five hundred seventythree (81%) had medical comorbidities, and 531 (74%) had previously undergone abdominal surgery, pelvic surgery, or both.
Procedures are presented in Table 1 . Three hundred sixty operations (51%) were gynecologic oncology procedures, which included laparoscopic-assisted oophorectomy for ovarian masses longer than 15 cm, laparoscopic hysterectomy and lymphadenectomy, laparoscopic hysterectomy for fibroids weighing more than 500 g, 15 laparoscopic radical hysterectomy, 12 laparoscopic-assisted ovarian debulking, 13 laparoscopic ovarian cancer staging, 14 modified radical vulvectomy, debulking and bowel resection with laparotomy, ovarian debulking with laparotomy. The other 357 operations (49%) were gynecologic procedures. Diagnoses are presented in Table 2 . Four hundred two patients (56%) had gynecologic cancers, including cervical, endometrial, ovarian, and vulvar.
Median blood loss was 100 mL (range, 0-800 mL), median Of the 707 patients who underwent surgical procedures, 6 patients had postoperative ileus as defined by the study criteria, with 1 patient experiencing 2 episodes of ileus, for 7 episodes total: 5 patients' hospital discharges were delayed 1 to 2 days after laparoscopic-assisted ovarian debulking, 1 patient's discharge was delayed 2 days after laparoscopic hysterectomy and lymphadenectomy, and 1 patient was readmitted to the hospital for nausea 2 days after laparoscopicassisted ovarian debulking (this patient was also 1 of the 5 patients whose hospital discharge was delayed 1-2 days, Table 3 ). All 7 episodes were managed with diet of choice and continued bowel stimulation.
No patients experienced nasogastric tube decompression, serious adverse effects associated with bowel stimulation, or postoperative bowel obstruction. Two patients (0.3%) had postoperative intestinal leak. In both instances, a small perforation of the rectosigmoid colon formed after laparoscopic oophorectomy for an ovarian mass greater than 15 cm. Both events necessitated reoperation.
Twenty-one patients (3%) had nongastrointestinal morbidity, including acute tubular necrosis, congestive heart failure, hyponatremia, sarcoid respiratory failure, pulmonary embolism, urinary retention, pneumonia, urinary tract infection, and wound infection.
Comment
The incidence of ileus after gynecologic-oncologic surgical procedures is approximately 15%. [4] [5] [6] [7] [8] [9] In an effort to prevent ileus, we employed immediate postoperative feeding and bowel stimulation. Even with a liberal definition of postoperative ileus, our [4] [5] [6] [7] [8] [9] Abbreviations: LOS, length of hospital stay. study findings showed a 1% incidence of ileus, with no patients requiring nasogastric tube decompression. We believe our low rate of ileus is directly related to immediate feeding and bowel stimulation. Another factor that could have contributed to the low rate of postoperative ileus in our study is our emphasis on minimally invasive operations-87% of our surgical procedures were laparoscopic, laparoscopic-assisted, or vaginal. In addition, we used ketorolac tromethamine, which may decrease the gastrointestinal inflammatory response. In 1 prospective randomized trial, 17 the use of ketorolac tromethamine statistically significantly reduced the incidence of postoperative ileus in patients who underwent a colorectal surgical procedure. We also believe our extensive pre-and postoperative patient education concerning ileus and bowel stimulation may have allowed patients to better tolerate postoperative intestinal functioning. There were no serious adverse effects associated with bowel stimulation. There were no cases of postoperative bowel obstruction, but there were 2 cases of intestinal leak (0.3%), which required reoperation.
In a search of the US National Library of Medicine's PubMed database, we were able to locate 4 trials 10,11,17,18 of postoperative bowel stimulation (Table 4) , including 2 of our trials 10,11 that examined postoperative bowel stimulation after radical hysterectomy. In our first trial of bowel stimulation without immediate feeding, mean hospital stay was reduced from 8 days to 4 days. 10 In our second trial of bowel stimulation with immediate feeding, mean hospital stay was reduced to 3 days. 11 Other studies produced similar findings: a Danish prospective randomized study 18 indicated that bowel stimulation decreased time to bowel movement by 35%, and a prospective randomized study 19 with patients who underwent colorectal surgical procedures revealed that bowel stimulation 
Conclusion
To our knowledge, the present trial is the largest trial to date to evaluate immediate postoperative feeding and bowel stimulation in patients undergoing gynecologic surgical procedures. We believe immediate postoperative feeding and bowel stimulation are safe and effective in the prevention of ileus after gynecologic operations.
